Skip to main content

Table 1 Characteristics of SLE patients and controls subjects

From: High-sensitivity cardiac troponin T is a biomarker for atherosclerosis in systemic lupus erythematous patients: a cross-sectional controlled study

Ā 

SLE (nā€‰=ā€‰63)

Controls (nā€‰=ā€‰18)

p value

Age, years

39 (29ā€“63)

41 (30ā€“61)

0.357

Female gender, n (%)

52 (82.5)

14 (77.8)

0.646

Smoker current, n (%)

24 (38.1)

8 (44.4)

0.627

LDL cholesterol, g/L

0.90 (0.36ā€“1.53)

1.22 (0.74ā€“1.72)

0.001

Hypertension, n (%)

16 (25.4)

4 (22.2)

0.783

SBP, mm Hg

125 (100ā€“166)

125 (108ā€“184)

0.498

10-Year cardiovascular riska, %

1 (1ā€“18)

1 (1ā€“13)

0.416

Overweightb, n (%)

24 (38.1)

8 (44.4)

0.627

Waist circumference, cm

90 (74ā€“150)

91 (74ā€“117)

0.852

eGFRc, mL/min/1.73Ā m2

92 (54ā€“127)

76 (60ā€“99)

0.221

HbA1c, %

5.5 (4.4ā€“6.7)

5.5 (4.6ā€“6.5)

0.988

Antiplatelet treatment, n (%)

7 (11.1)

1 (5.6)

0.486

Statin, n (%)

15 (23.8)

2 (11.1)

0.139

ACE inhibitors, n (%)

16 (25.4)

3 (16.7)

0.440

ARBs, n (%)

5 (7.9)

0

0.217

Carotid plaqued, n (%)

23 (36.5)

2 (11.1)

0.039

  1. Results are shown as median (range) or number (percentage)
  2. Analysis was performed on 81 subjects
  3. a10-year cardiovascular risk was calculated using the Framingham equation
  4. bOverweight was defined as a body mass index >25Ā kg/m2
  5. cEstimated glomerular filtration rate (eGRF) was calculated with the Modification of Diet in Renal Disease (MDRD) equation
  6. dCarotid plaques were defined as an internal carotid wall thickness at the carotid bulb >1.5Ā mm
  7. ACE Angiotensin converting enzyme, ARB Angiotensin II receptor antagonist, HbA1c haemoglobin A1c, LDL low-density lipoprotein, SBP systolic blood pressure, SLE systemic lupus erythematosus